Stocks · Korea
215380
KOSDAQ
Kolmar BioTech
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
Returns and 52-week range
1W+7.51%
1M+15.95%
3M+0.00%
6M-9.98%
1Y+37.57%
YTD+36.80%
52W high4,535원
52W low1,616원
From 52W high-46.31%
Financial results (separate)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 469억 | -25억 | -19억 | -5.4% |
| 2023 | 386억 | -45억 | -51억 | -11.6% |
| 2024 | 432억 | 18억 | 2억 | 4.1% |
| 2025 | 376억 | -39억 | -55억 | -10.4% |
| Quarterly | ||||
| 2024 4Q | 120억 | 10억 | 5억 | 8.5% |
| 2025 1Q | 83억 | -14억 | -21억 | -16.9% |
| 2025 2Q | 71억 | -16억 | -15억 | -22.7% |
| 2025 3Q | 98억 | -9억 | -6억 | -9.0% |
| 2025 4Q | 124억 | -13,400,511원 | -13억 | -0.1% |
| 2026 1Q | 110억 | 4억 | -2억 | 3.9% |
Company
Address: 경기도 화성시 동탄기흥로 593-8 콜마 바이오클러스터
Peers in the same sector
Recent filings
- 2026-08-14반기보고서 (2026.06)
- 2026-07-21[기재정정]주요사항보고서(회사합병결정) Major
- 2026-07-20주요사항보고서(회사합병결정) Major
- 2026-05-15분기보고서 (2026.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.